These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26847828)
1. The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies. Sun XS; Wen J; Li JX; Lai R; Wang YF; Liu HJ; Sheng WL Mol Genet Genomics; 2016 Jun; 291(3):1193-203. PubMed ID: 26847828 [TBL] [Abstract][Full Text] [Related]
2. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects. Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926 [TBL] [Abstract][Full Text] [Related]
3. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Liao X; Deng J; Dai W; Zhang T; Yan J Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161 [TBL] [Abstract][Full Text] [Related]
4. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis. Huang Y; Cheng D; Zhang J; Zhao W J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China. Sun X; Luo M; Li J; Lai R; Lin J; Wang Y; Xu X; Wu S; Sheng W Mol Genet Genomics; 2020 May; 295(3):635-643. PubMed ID: 32020275 [TBL] [Abstract][Full Text] [Related]
6. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis. Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population. Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801 [TBL] [Abstract][Full Text] [Related]
8. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans. Park MG; Shin JH; Lee SW; Park HR; Park KP J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162 [TBL] [Abstract][Full Text] [Related]
9. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis. Ma J; Liu Y; Ma L; Huang S; Li H; You C Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837 [TBL] [Abstract][Full Text] [Related]
10. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea. Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859 [TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275 [No Abstract] [Full Text] [Related]
12. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847 [TBL] [Abstract][Full Text] [Related]
13. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature. Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898 [TBL] [Abstract][Full Text] [Related]
14. Predictive role of heterozygous p.R4810K of Wang Y; Zhang Z; Wei L; Zhang Q; Zou Z; Yang L; Li D; Shang M; Han C; Mambiya M; Bao X; Li Q; Hao F; Zhang K; Wang H; Liu S; Liu M; Zeng F; Nie F; Wang K; Liu W; Duan L Neurology; 2020 Feb; 94(7):e678-e686. PubMed ID: 31949090 [TBL] [Abstract][Full Text] [Related]
15. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593 [TBL] [Abstract][Full Text] [Related]
16. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease. Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845 [TBL] [Abstract][Full Text] [Related]
17. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. Kamada F; Aoki Y; Narisawa A; Abe Y; Komatsuzaki S; Kikuchi A; Kanno J; Niihori T; Ono M; Ishii N; Owada Y; Fujimura M; Mashimo Y; Suzuki Y; Hata A; Tsuchiya S; Tominaga T; Matsubara Y; Kure S J Hum Genet; 2011 Jan; 56(1):34-40. PubMed ID: 21048783 [TBL] [Abstract][Full Text] [Related]
18. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease. Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206 [TBL] [Abstract][Full Text] [Related]
19. Differences in the Genotype Frequency of the RNF213 Variant in Patients with Familial Moyamoya Disease in Kyushu, Japan. Takamatsu Y; Higashimoto K; Maeda T; Kawashima M; Matsuo M; Abe T; Matsushima T; Soejima H Neurol Med Chir (Tokyo); 2017 Nov; 57(11):607-611. PubMed ID: 28931766 [TBL] [Abstract][Full Text] [Related]
20. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease. Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]